Assessing the therapeutic potential of an AAV-based gene therapy in SYNGAP1 haploinsufficiency

• Principal Investigator: Peter Kind, PhD
• Institution: University of Edinburgh
• Grant Number: 2022.8
• Funding Amount: $180,000
• Percentage Dispersed: 50%
• Grant Status: Signed & Active

You can find our press release here.